Back to search

Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells

Data up to Jan 2025

Published2006
Citations232
References21

Total Citations Per Year

Abstract

References (21)

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

2002 • 1,529 citations

Roles of the NKG2D immunoreceptor and its ligands

2003 • 1,297 citations

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

2005 • 1,246 citations

ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor

2001 • 1,190 citations

ADAMs: key components in EGFR signalling and development

2005 • 1,056 citations

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

2001 • 1,036 citations

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

1996 • 1,010 citations

Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB

1999 • 1,006 citations

Regulation of Cutaneous Malignancy by γδ T Cells

2001 • 945 citations

Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells

2001 • 937 citations

Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells

2003 • 639 citations

Membrane protein secretases

1997 • 634 citations

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

2002 • 624 citations

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

2003 • 510 citations

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

2002 • 509 citations

Prevalent expression of the immunostimulatory MHC class I chain–related molecule is counteracted by shedding in prostate cancer

2004 • 297 citations

RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivo

2004 • 288 citations

Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human Neuroblastoma

2004 • 254 citations

Prevalent expression of the immunostimulatory MHC class I chain–related molecule is counteracted by shedding in prostate cancer

2004 • 253 citations

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

2002 • 240 citations

A Novel Secreted Tumor Antigen with a Glycosylphosphatidylinositol-Anchored Structure Ubiquitously Expressed in Human Cancers

2001 • 29 citations

Cited By (0)

No citing papers found in database

Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells (2006) – Cancer Research | Metascience Observatory Explorer